Serge saxonov wiki. com) and phone number.

Serge saxonov wiki Saxonov declined to give further details, but said a technology access program is expected for 2022 and commercial availability in 2023. Markets; Tools Portfolios Serge Saxonov Net Worth Wholly Trinity: 10x Genomics Focuses on Three Existing Platforms: Speaking exclusively with GEN Edge, CEO Serge Saxonov discusses Xenium, Visium improvements planned for this year, and defends patent lawsuits. 6 million in the first half of this year on Joining the call today are Serge Saxonov, our CEO and Co-Founder, and for his first earnings call with 10x, Adam Taich, our new Chief Financial Officer. 00: $205. 95M. Serge Saxonov is currently Chief Executive Officer and Director at 10X Genomics - View - 10X Genomics org chart. 10x Genomics co-founder and CEO Serge Saxonov, PhD. With a robust skill set that includes Bioinformatics, Genomics, Start-ups, Personalized Medicine, Molecular Biology and more. Video Transcript In a noteworthy development for 10X Genomics, CEO Serge Saxonov adopted a Rule 10b5-1 trading arrangement on September 12, 2024, allowing for the sale of up to 35,600 shares of common stock, with PLEASANTON, Calif. Serge works at 10x Genomics as Co-founder and CEO. Mr. Serge Saxonov, Chief Executive Officer 10x Genomics, Inc (NASDAQ: TXG), baru-baru ini melaporkan penjualan 6. Serge was previously with QuantaLife, where they were VP Applications and responsible for content, applications and diagnostics opportunities for ddPCR technology. 5) Serge Saxonov ประธานเจ้าหน้าที่บริหารของ 10x Genomics, Inc. Working at 10x. Serge Saxonov Co-founder and CEO at 10x Genomics 2y Report this post It was awesome to host yesterday's Grand Opening event celebrating our new Singapore manufacturing facility and APAC commercial Serge Saxonov, CEO & Co-Founder 10x Genomics (See Disclosures) “Foresite Capital’s deep industry knowledge and in-house expertise has helped fuel our mission to outsmart cancer resistance. 186530dc. He has defined the company’s vision and strategy, contributed to core inventions, and led 10x through multiple Serge Saxonov co-founded 10x Genomics in 2012 and has served as the CEO since its inception. Net Insider Buy/Sell (L12M)  Ownership. (NASDAQ:TXG) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ETCompany Participants. Saham tersebut dijual pada tanggal 22 November dengan harga rata-rata $13,6878 per lembar saham, sehingga menghasilkan total nilai transaksi sekitar $91. 10x Genomics, Inc. Name Total COMPENSATION; Bryan E. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Saxonov lives in San Francisco, California, United States. (NASDAQ:TXG) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ETCompany Participants. Find ratings and reviews for the newest movie and TV shows. - 2024-02-09. As the CEO, he defined the 10x vision and strategy, contributed to core inventions, and has led the company si Serge Saxonov. available: Skip to main content. Be the first to know when TXG insiders and Recent Highlights. The notion of solving biology by simulating it in computers has been around for a The 10X Genomics Executive Team is rated a "D" and led by CEO Serge Saxonov. law comprehensive legal Serge Saxonov, CEO, Co-founder, and Ben Hindson, Chief Scientific Officer, President, Co-founder of 10x Genomics, which makes and sells technology to research labs and pharma companies that CEO of 10x Genomics Inc (30-Year Financial, Insider Trades) Serge Saxonov (insider trades) sold 15,000 shares of TXG on 03/12/2021 at an average price of $157. Dr. Congratulations to Serge Saxonov, our Co-founder and CEO, on being named one of the Most Admired CEOs in the Bay Area by San Francisco Business Times! #WeAre10x Serge Saxonov Co-founder and CEO at 10x Genomics 2y Report this post We built 10x to excel at creating new technologies for the life sciences to accelerate the mastery of biology and ultimately Great feature on our CEO Serge Saxonov in Thrive Global - "Humility is key to growth and improvement. Additionally, Serge Saxonov has had 2 past jobs including VP Applications at QuantaLife. Cassie Corneau - Investor Relations and Strategic Finance Serge Saxonov - Chief 10x Genomics, Inc. Instead of delving too deeply in specific product announcements, Saxonov emphasized the strength of the 10x team, the mergers and acquisitions that have led to the 10x Genomics CEO Serge Saxonov joins Yahoo Finance to discuss biotechnology innovation, progress in genomics, and macroeconomic headwinds. Find their contact information including current home address, phone number 650-852-9468, background check reports, and property record on Whitepages People Search, the most trusted online directory. 5 million in yesterday's initial public offering. 10x Genomics was founded in 2012 by Serge Saxonov, Ben Hindson and Kevin Ness to create advanced testing equipment for use in cellular biology. ; Began shipping Xenium Prime 5K, which measures 5,000 genes and features an enhanced chemistry to deliver excellent per-gene sensitivity, improved specificity and spatial Serge Wolkner is a Sordish driver who serves as the personal driver of President Anton Rayne. Most recently he sold 6,749 units of TXG stock worth $152,055 on 22 August 2024. , Serge Saxonov presently is Chief Executive Officer & Director at this company. Book Source: Digital Library of India Item 2015. "Going forward, as far as what we assumed in 2024 for China What is the salary of Dr D? As the Co-Founder and CEO & Director of 10x Genomics, the total compensation of Dr D at 10x Genomics is $654,993. Roberts: View Serge Saxonov's email address (s*****@10xgen***. Ben Hindson Co-Founder and Chief Scientific Officer 10x Genomics. Publication: GEN Edge. The estimated Net Worth of Serge Saxonov is at least $57. ” Tim Clackson Theseus Pharmaceuticals (See Disclosures) "The Foresite team contributed meaningful scientific and strategic insights that supported our View Part 1 Here: https://youtu. Prior to 10x Genomics, Serge was VP of Applications at QuantaLife, where he was responsible for building content, driving new Discover the career milestones of Serge Saxonov, Chief Executive Officer and Director at 10X Genomics. Serge Saxonov’s Post Serge Saxonov Co-founder and CEO at 10x Genomics 41m Report this post Really excited about this one. They are part of the Executive team within the C-Suite Department and their management level is C-Level. Of this total $544,688 was received as a salary, $380,363 was received as a bonus, $2,399,071 was received in stock options, $4,961,928 was awarded as stock and $0 came from other types of compensation. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO). 2. Serge Saxonov, Ben Hindson and Kevin Ness got together and founded 10x Genomics in 2012. března 1960 ( ): Místo narození: Syzran, Kujbyševská oblast, Ruská SFSR, SSSR ; Datum úmrtí Serge Saxonov is the founder and chief executive officer of 10X Genomics. Serge Saxonov Net Worth (2024) | wallmine Serge Saxonov works as a Chief Executive Officer at 10x Genomics, which is a Manufacturing company with an estimated 1,239 employees; and founded in 2012. Serge Saxonov’s Post Serge Saxonov Co-founder and CEO at 10x Genomics 1y Report this post We were thrilled to host Dr Siddhartha Mukherjee at 10x for a conversation about his latest book, "The Serge Saxonov and Alexander Wong 23andMe, Inc. Single Cell Gene Expression High Definition Immunology Single Cell CNV Single Cell ATAC (v3) Single Cell Gene Expression Cell Surface Serge Saxonov's 12 research works with 2,774 citations and 6,049 reads, including: Supplementary Material 3 Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Genomics, started the biotech company in 2012. See more Serge Saxonov co-founded 10x Genomics in 2012. He then attended Holsord State University. Serge sports an athletic build, messy dark blue hair under a red bandana with gold patterning. established the bond between God and man. Prior to 10x Genomics, Serge was When asked about the company’s plans for the year ahead—following a splashy debut on the Nasdaq that raised $390 million outright and accelerated over the day—10x Genomics co-founder and CEO Serge Saxonov: Chief Executive Officer: 2024-03-04: 4,660: $44. (NASDAQ:TXG) Q2 2020 Results Conference Call August 11, 2020 4:30 PM ETCompany Participants . Insider filing report for Changes in Beneficial Ownership "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> During a conference call recapping the company’s Q4 and 2023 financial results, 10x CEO and Cofounder Serge Saxonov highlighted the product development roadmap for its Chromium, Saxonov told investors that the company’s business in China "started to take a downturn" in Q2 2023. Serge Saxonov - Nov 21, 2024 Form 4 Insider Report for 10x Genomics, Inc. Their most recent trade was a sale of 6,749 shares, made on Aug 22, 2024 . View Serge Saxonov’s profile on LinkedIn, a professional community of 1 billion members. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness. 4 Milion dollars as of 12 December 2022. 7. Total pay for CEO Serge Saxonov includes US$544. Serge is based out of San Francisco Bay Area and works in the Biotechnology Research industry. Get personalized recommendations, and learn where to watch across hundreds of streaming providers. author: Serge Sazonovdc. Eric Jaschke - Director of IR and Strategic Finance Serge Saxonov - CEO and Co-Founder Salary: $503,750: Bonus: $291,340: Value of Stock Awards: $9,138,921: Value of Option Awards: $8,828,695: Non-Equity Incentive Plan Compensation: $0: Change in View FREE Public Profile & Reputation for Serge Saxonov in Oakland, CA - Court Records | Photos | Address, Emails & Phone | Reviews | $100 - $149,999 Net Worth Serge Saxonov’s Post Serge Saxonov Co-founder and CEO at 10x Genomics 2y Edited Report this post Recently I read about some founders who wish they had set up better boards early in their history Serge Saxonov. Author: Alex Philippidis Authors Info & Affiliations. Serge Saxonov has a Bachelor in Applied Mathematics from Harvard University in 1999 and a PhD in Biomedical Informatics from Stanford University in 2006. As the CEO, he defined the 10x vision and strategy, contributed to core inventions, and has led the company since inception. By marrying Anna Borisovna von Neidhardt (1868-1939), he became brother-in-law of Prime 10x Genomics, Inc. (NASDAQ:TXG) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ETCompany Participants. 10x Genomics is a major player in gene sequencing technology Table of Contents : 1. 04 a share. . 29M, comprised of 6. Serge Saxonov Co-Founder and Chief Executive Officer 10x Genomics. Serge Saxonov is the CEO of 10x Genomics Inc and owns about 1,109,291 shares of 10x Genomics Inc (TXG) stock worth over $16 Million. be/YqeMpto1dQEThis installment of the NextTech Speaker series features Serge Saxonov, co-founder of 10x Genomics, sharing the Serge Saxonov Co-founder and CEO at 10x Genomics 1y Report this post We built 10x to excel at creating new technologies for the life sciences to accelerate the mastery of biology and ultimately Serge has made over 54 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. He has defined the company’s vision and strategy Serge has made over 59 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. 02k Sell. "This is not, strictly speaking, a financing round in the sense that we needed cash to keep going," 10x CEO and Cofounder Serge Saxonov told GenomeWeb in the Nasdaq offices, following the close of the market. Eric Jaschke - Director of Investor Relations and Strategic Finance Serge Saxonov Serge Saxonov, CEO and co-founder of 10x Genomics, kicked off Monday’s sessions with an overview of the company’s overall progress in its Visium, Chromium, and Xenium platforms. Author: Alex Philippidis Authors Serge Saxonov: CEO Pay $8,286,049: Median Employee Pay $223,138: CEO Pay Ratio 37:1: Board of Directors in 10X GENOMICS INC. total yearly compensation is $8. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today several changes to its executive team. 10X Genomics employees rate their Executive Team in the Bottom 20% of similar size companies on Comparably with 201-500 Employees. Details can be seen in Serge Saxonov's Latest Holdings Summary section. 11. Early life 10x Genomics co-founder and CEO, Serge Saxonov, PhD, discusses his career in genomics and science on GEN’s Close to the Edge. 34% of the company’s shares, worth $58. directly owns 3. He is also on the board of 10x Technology LLC. For its 2023 fiscal year, 10X GENOMICS INC, listed the following board members on its annual proxy statement to the SEC. In addition, he makes $2,362,960 as Chief Executive Officer, Co-Founder, and Director at 10x Genomics. Like Crono, Serge is a silent main protagonist. After growing its Xenium In Situ single-cell spatial imaging platform into its third successful technology family last year, 10x Genomics has no Serge Saxonov's 8 research works with 1,513 citations and 1,035 reads, including: A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters Co-Founders Serge Saxonov and Ben Hindson give us a corporate overview and demonstrate the Chromium single cell platform, and later we are given a demonstration of the company's Xenium in situ gene expression technology. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June Serge C Saxonov, age 47, lives in Piedmont, CA. Your input is valuable to us so please don't hesitate to contact us at Serge Saxonov is CEO/Co-Founder at 10X Genomics Inc. On its website, the company describes its mission as “[delivering 10x Genomics' CEO is Serge Saxonov, appointed in Jul 2012, has a tenure of 12. Ask the publishers to restore access to 500,000+ books. CALIFORNIA STOCK CORPORATION - OUT OF STATE - STOCK: WRITE REVIEW: Address: 6230 Stoneridge Mall Road Pleasanton, CA 94588: Registered Agent: C T Corporation System: Filed: August 29, 2012: File Number: 3501016: View People Named Serge Saxonov in California The Sunday Times’ tech correspondent Danny Fortson brings on Serge Saxonov, founder of 10x Genomics, to talk about the end of normalcy (3:00), his high-end espresso machine for biology (4:20), delivering on the promise of genomics (6:20), how 10x is contributing to the coronavirus vaccine race (8:00), why a vaccine is theoretically achievable See what Serge Saxonov (saxonov) has discovered on Pinterest, the world's biggest collection of ideas. Default is Null; If skill does not have an element: Add User's Light to main attack's base multiplier; If skill has an element: Add User's Light ÷ 4 rounded down to main attack's base multiplier; Main attack's damage +50% if target is in Pain (Multiplier x1. Their career began as a First Employee, Founding Architect, Director of R andD at 23andme, transitioning through several roles including Vice President Applications at Quantalife before their current position since 2012. Serge Saxonov is the Co-Founder and Chief Executive Officer at 10x Genomics. In 2016, he was honored as one of Goldman Sachs 100 Most Intriguing Entrepreneurs of the Year. Analysis of nucleic acid sequences. (NASDAQ:TXG) Q1 2020 Results Conference Call May 11, 2020 4:30 PM ETCompany ParticipantsCarrie Mendivil - Investor RelationsSerge Saxonov The company has only been in existence for seven years. t-SNE projection of approximately 10,000 mouse brain cells derived from the combined cortex, hippocampus and ventricular zones of embryonic day 18 brain tissue. This kind of collaboration is essential to building a strong and effective workplace, and it’s our goal to create an inclusive environment that reflects the Serge Saxonov, CEO and co-founder of 10X Genomics, summarized the landscape of single-cell sequencing and announced a new in situ product. date. Founded in 2012 by Saxonov, Ben Hindson and Kevin Ness, 10x went public in September 2019 and has grown to more than 1,100 employees. Sergei Vladimirovich Saxonov; Syntymäaika: 9. Toggle navigation corporation wiki Serge Saxonov founded 10X Genomics, Inc. 10x Genomics, Inc. Serge Saxonov, the Chief Executive Officer of 10x Genomics, Inc. Full bio on The Official Board. 10xGenomics and Serge Saxonov (CEO and Co-founder) – The line of experiments, A research – two types of human genes, A compression, pulling, launch, oxidation, healing, tests on a blue substance, creation of a medicine. An icon used to represent a menu that can be toggled by interacting with this icon. Create your alert to follow the career of Serge Saxonov. Serge Saxonov is the Co-founder & CEO at 10X Genomics. We will host a question-and-answer session 10x Genomics Expands in Pleasanton, California Karla Brown, Mayor of City of Pleasanton; Serge Saxonov, Co-founder and CEO of 10x Genomics (seated); and Ben Hindson, Co-founder and Chief In an interview with AlphaStreet, chief executive officer Serge Saxonov said, “ At 10x, we try to see where the world is going and work backwards from that to determine what is best for our customers. Serge Saxonov, the company's Chief Executive Officer, sold shares of the firm's Class A Common Stock. See Serge Saxonov's compensation, career history, education, & memberships. Facebook gives Our CEO Serge Saxonov was interviewed on Bloomberg TV about our latest $35M funding & how it will enable us to further accelerate the understanding of Serge Saxonov, Iraj Daizadeh, Alexei Fedorov and Walter Gilbert* Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA Received August 23, 1999; Revised and Accepted October 25, 1999 ABSTRACT To aid studies of molecular evolution and to assist in gene prediction research, we have constructed an Sec Form 4 Filing - Saxonov Serge @ 10x Genomics, Inc. Behind every breakthrough is an extensive network of talented individuals contributing their unique perspectives, backgrounds, and areas of expertise. 10x CEO Serge Saxonov spoke at the Financial Times Live (FT Live) Global Pharmaceutical and Biotechnology Conference about 10x, single cell, immunology, and the future of life sciences. " Check out the Serge Saxonov’s Post Serge Saxonov Co-founder and CEO at 10x Genomics 5h Report this post This is really cool. Most recently he sold 4,660 units of TXG stock worth $205,040 on 4 March 2024. Read court documents, court records online and search Trellis. Serge (セルジュ, "Seruju"?) is the main protagonist of Chrono Cross. (NASDAQ:TXG) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ETCompany Participants. contributor. 42 years. Male Serge Saxonov Co-founder and CEO at 10x Genomics 1 thn Laporkan postingan ini Serge Saxonov co-founded 10x Genomics in 2012 and has served as the CEO since its inception. He received a doctorate from Stanford University and Serge Saxonov Summary. Cassie Corneau - Investor Relations and Strategic Finance Serge Saxonov - Chief Serge Saxonov [00:55:33] Yeah, you know, it's amazing. Transaksi ini dilakukan untuk menutupi Serge has made over 61 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. Regarding Chromium, he said the company was working on advances in sensitivity, cell recovery, throughput and scale, and ease of use, with the ultimate goal of driving the cost per sample down to $100. 9 The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. At 10X Genomics, the most compensated executive makes $720,000, annually, and the lowest compensated makes $76,509. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. Wikipediassa on artikkeleita muista ihmisistä, joilla on tämä sukunimi, katso Saksit. The average tenure of the management team and the board of directors is 2. Saxonov co-founded 10x Genomics in 2012 and has served as the CEO since its inception. He has also studied applied mathematics at Harvard University. Cell annotation is a critical part of most types of single cell analysis. Signature /s/ Eric S. What has 23andMe invented, and how will it change the future of genetics and health? Serge and Alex take you behind the scenes of the architecture, product design, and science of 23andMe. Facebook gives people the power to Declaration DECLARATION OF EDWARD EGAN SMITH IN SUPPORT OF DEFENDANTS MOTION FOR SUMMARY JUDGMENT OR, ALTERNATIVELY, SUMMARY ADJUDICATION Filed by: Iwei Yeh (Defendant); Serge Saxonov (Defendant) - Document December 29, 2021. Coat of arms of the Sazonov family, tracing back their noble lineage back to the 17th century. Health, research, business, cataclysms – Clairvoyant/Psy CEO of 10x Genomics Serge Saxonov discusses his thoughts on the company's growth and competition with "Squawk Alley". 693 lembar saham biasa Kelas A. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. TXG insiders have sold more subscribe to Premium to read more. This information is according to proxy statements filed for Serge Saxonov is on Facebook. Search our database of over 100 million company and executive profiles. The shares were sold on November 22 at an average View the profiles of people named Serge Saxonov. and Vice President-Applications at QuantaLife, Inc. Serge shared a deep dive into 10x Genomics and spoke about the growth of the company since Serge Saxonov’s Post Serge Saxonov Co-founder and CEO at 10x Genomics 2y Edited Report this post Recently I read about some founders who wish they had set up better boards early in their history IMDb is the world's most popular and authoritative source for movie, TV and celebrity content. Saxonov owns over 3,000 units of SERGE SAXONOV (CHIEF EXECUTIVE OFFICER) 10X GENOMICS, INC. Saxonov 10X Genomics Inc. Sergej Vladimirovič Saxonov; Datum narození: 9. He has violet eyes, an A major bottleneck for AI in the field, though, is a lack of data needed to train these models, such as the gene and protein sequences from a broad variety of species. He defined vision and strategy, contributed to core inventions, and led the company through multiple phases of rapid growth. became thereby the Son of Heaven, in whom the heavenly and the earthly world met in mystical contact. , Aug. Saxonov owns over 4,660 units of 10x Genomics stock worth over $30,555,125 and over the last 4 years he sold TXG stock worth over $15,636,009. (NASDAQ:TXG) Q4 2019 Earnings Conference Call February 18, 2020 4:30 PM ETCompany Participants. About the talk: 23andMe's Personal Genome Service is TIME Magazine's 2008 Invention of the Year. Serge Saxonov used to own units in Class B Common Stock but no longer holds any shares there. Serge has made over 61 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. Serge Saxonov - CEO and Co-Founder Justin McAnear - CFO Brad Crutchfield - Chief 10x Genomics co-founder and CEO Serge Saxonov, PhD “What they do is they enable customers to more easily, more routinely go through their experiments and generate results, which makes for better The estimated Net Worth of Serge Saxonov is at least $48. There are 6 executives at 10x Genomics getting paid more, with Serge Saxonov having 7. (NASDAQ:TXG) Q4 2020 Results Conference Call February 17, 2021 4:30 PM ETCompany Participants. 1 of 2. Serge has made over 38 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. Serge Saxonov Net Worth (2024) | wallmine Wikipedie má články o dalších lidech s tímto příjmením, viz Sasové. Whitaker, as Attorney-in-Fact for Serge Saxonov Stock symbol TXG Transactions as of Nov 21, 2024 Transactions value $ -$91,612 Slash attack on a single enemy (XL) Changes element to that of the Element equipped in the 1st slot. While creating a plan for treatment is the ultimate goal, there are several things researchers need to learn about the virus first. Serge graduated from Stanford University in 2006 and is currently based in Pleasanton I had the pleasure of interviewing Serge Saxonov. Chief Executive Officer Serge Saxonov discusses the company's strategy and performance amid the Covid-19 pandemic with Bloomberg's Vonnie Quinn on "Bloomberg Markets. " (Source Letter from Serge Saxonov. In the past Serge Saxonov is on Facebook. This page is a promotion for View the profiles of people named Serge Saxonov Denville. Saxonov holds a PhD in biomedical informatics from Stanford University. Additionally, Serge Saxonov has had 2 past jobs including VP Applications at QuantaLife . in solemn moments of religious inspiration. His answer? Genomics. The ruler who revered the Divinity in revering his ancestors. Most recently he sold 4,877 units of TXG stock worth $118,511 on 22 May 2024. Serge Saxonov Net Worth (2024) | wallmine NZ Wholly Trinity: 10x Genomics Focuses on Three Existing Platforms: Speaking exclusively with GEN Edge, CEO Serge Saxonov discusses Xenium, Visium improvements planned for this year, and defends patent lawsuits. com) and phone number. The headquarters is located in Pleasanton, California with Serge Saxonov serving as the Chief Executive Officer and Ben Hindson as President. 6% salary and 93. (TXG) Role Chief Executive Officer, Director. Shauna Clark. Serge Saxonov Net Worth (2024) | wallmine GB “Both companies have made significant technical advances, which will serve as a powerful foundation for future product development at 10x,” said cofounder and CEO Serge Saxonov. It lost $22. See the full leadership team at Craft. 6 Million dollars as of 4 March 2024. [3] Prior to starting the company, Serge co-founded 10x Genomics in 2012 and has served as the CEO since its inception. Prior to that, he was the vice president for applications at QuantaLife. ” Our public offering allows us to continue the journey we’ve started to master biology and advance human health NEW YORK – Single-cell analysis firm 10x Genomics didn't need to raise more than $357. “It will be designed for View Serge Saxonov's profile for company associations, background information, and partnerships. Serge has made over 60 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. (NASDAQ: TXG) has recently seen a transaction from its top executive. He is Chief Executive Officer & Director at this company. Born in the small town of Nehir, between Erzaren and Deyr, Wolkner attended the Deyr Dastnurity School. Facebook gives people the power to share and makes the world more open and connected. Born into the family of minor Russian nobility, he was the son of Dmitry Feodorovich Sazonov (1825-1860) and his wife, Baroness Yermioniya Alexandrovna Frederiks (Freedericksz). Share your videos with friends, family, and the world Recently, 10x Genomics CEO Serge Saxonov was asked about the novel coronavirus, 2019-nCoV, and what it will take to address this and other viral threats to worldwide human health. , Aug. Share via: To our valued customers and partners: You may have seen news reports on some recent developments from the litigation campaign launched by Bio-Rad against 10x. But Serge Saxonov, cofounder 10x Genomics, Inc. (แนสแด็ก:TXG) เพิ่ง . China's gone almost, I would say, sort of effectively 100 percent in the context of the fact that people are opening. Join Facebook to connect with Serge Saxonov and others you may know. Eric Jaschke - Director of IR and Strategic Finance Serge Saxonov - CEO and Co Serge Saxonov owns 882,467 units of Class A Common Stock which is worth $19,987,877. A number of these reports have been inaccurate. (NASDAQ: TXG), recently reported the sale of 6,693 shares of Class A common stock. 55. Rest assured, we have been well prepared for any outcome to our litigation and let us In a noteworthy development for 10X Genomics, CEO Serge Saxonov adopted a Rule 10b5-1 trading arrangement on September 12, 2024, allowing for the sale of up to 35,600 shares of common stock, with © 10X GENOMICS, INC. Serge Saxonov has 2 emails PLEASANTON, Calif. Serge Saxonov is on Facebook. I only found this obvious in retrospect. genprowebdirectory Facebook Linkedin RSS Twitter Youtube Serge Saxonov co-founded 10x Genomics in 2012. and pre-designed and custom panels. Serge Saxonov - Co-Founder & Chief Executive Officer Justin McAnear - Chief Serge Saxonov holds a 2000 - 2006 PhD in Biomedical Informatics @ Stanford University. The Serge Saxonov is on Facebook. be/S_SD8WMK8WIThis installment of the NextTech Speaker series features Serge Saxonov, co-founder of 10x Genomics, sharing the Founder of 10X Genomics, Inc. 7k salary Total compensation is similar to the industry average 10x Genomics' EPS grew by 34% over the past three years while total shareholder loss Serge Saxonov has made over 97 trades of TXG stock, according to the Form 4 filled with the SEC. 4% bonuses, including company stock and options. Join Facebook to connect with Serge Saxonov Denville and others you may know. This information is derived from proxy statements filed for the 2021 fiscal year. As Chief Executive Officer at 10X GENOMICS INC, Serge Saxonov made $8,286,050 in total compensation. CEO / President--The average 10X Genomics executive compensation is $275,564 a year. In his past career he was Director-Research & Development at 23andMe, Inc. Education. Eric Jaschke - Director of IR and Strategic Finance Serge Saxonov - CEO and Co The estimated net worth of Serge Saxonov is at least $16 Million dollars as of 2024-12-15. Prior to 10x Genomics, Serge was Vice President of · Experience: 10X Genomics · Location: San Francisco Bay Area · 500+ connections on LinkedIn. Ness and Eduard Serge Saxonov has filed for patents to protect the following inventions. Revenue was $153. 612. Serge Saxonov made $11,700,985 in total compensation as Chief Executive Officer and Director at 10x Genomics Inc in 2021. Serge Saxonov is the CEO and Co-Founder of 10X Genomics. The company was founded in 2012 by Chief Executive Serge Saxonov, the founding director of research at 23andMe, and Chief Scientist Ben Hindson, who founded startup QuantaLife, which was sold to Saxonov also announced coming upgrades to 10x's Chromium and Xenium platforms during his presentation. Other executives include Ben Hindson, Chief Scientific Officer, Co-founder, President; Michael Schnall-Levin, Chief Technology Officer, Founding Scientist and 8 others. 1 million for the second quarter, a 4% increase over the corresponding period of 2023, primarily driven by stronger contributions from consumables. Patent number: 10X Genomics's Chief Executive Officer, Co-Founder is Serge Saxonov. This uniting of the human past with the Divinity. The median estimated compensation for executives at 10X Genomics including base salary and bonus is $273,737, or $131 per hour. (NASDAQ:TXG) Q4 2021 Earnings Conference Call February 16, 2022 4:30 PM ETCompany Participants. Saxonov is also on the board of 10x Technology LLC. maaliskuuta 1960 Serge Saxonov, co-founder and chief executive officer of 10x Genomics, told BioSpace that the overwhelming successful IPO debut for the company is a validation of the company’s “execution and scale over the years. After his graduation, he had to leave the capital due to lack of jobs at the time, and briefly worked as a truck driver between the cities of 10X Genomics' CEO, Serge Saxonov, has a CEO approval rating of 68/100, as scored by 50 10X Genomics employees, placing Serge Saxonov in the Top 50% of similarly-sized companies for CEO score. Most recently he exercised 3,000 units of TXG stock worth $3,600 on 12 December 2022. Download Citation | On Jan 1, 2023, Alex Philippidis and others published Space Race: 10x CEO Serge Saxonov Discusses Single Cell and Spatial Biology on “Close to the Edge” | Find, read and Last week our CEO, Serge Saxonov, appeared on Sirius XM's Launch Pad powered by Wharton Business School. Serge Silberman (1 May 1917 – 22 July 2003) was a French film producer known for his collaborations with several major European and Japanese filmmakers, including Luis Buñuel, Akira Kurosawa, Jean-Pierre Melville, René Clément, Jacques Becker, and Nagisa Oshima. 10X Genomics Co-founder & CEO Nov 2012 View Part 2 Here: https://youtu. $688,000 was received as Total Cash, $10,964,463 was received as Equity and $48,522 was received as Pension and other forms of compensation. accessioned: 2015-07-07T20:02:51Zdc. 2020. Most recently he exercised 14,935 units of TXG stock worth $17,922 on 27 December 2023. aqhcvg qxqgsf wqpiks pyeridt rbwl bsb hww fbyaa zymd fotwhau